Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats

Antioxidants and Redox Signaling

Volumn 20, Issue 5, 2014, Pages 759-769

  Liu, Yi Hong ^a   Lu, Ming ^a   Xie, Zhi Zhong ^a   Hua, Fei ^a   Xie, Li ^a   Gao, Jun Hong ^a   Koh, Yung Hua ^a   Bian, Jin Song ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN SULFIDE; ISOPRENALINE; LACTATE DEHYDROGENASE; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE B4; RENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; FEMALE; HEART; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; RENIN RELEASE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CARDIOTONIC AGENTS; CELL LINE; COLLAGEN; EPOXIDE HYDROLASES; FEMALE; HEART FAILURE; HEART VENTRICLES; HYDROGEN SULFIDE; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; LEUKOTRIENE B4; MAST CELLS; MYOCARDIUM; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RENIN; VENTRICULAR PRESSURE;

EID: 84893515527     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4888     Document Type: Article

References (41)

1. Batlle M, Perez-Villa F, Lazaro A, Garcia-Pras E, Ramirez J, Ortiz J, Orus J, Roque M, Heras M, and Roig E. Correlation between mast cell density and myocardial fibrosis in congestive heart failure patients. Transplant Proc 39: 2347-2349, 2007. (Pubitemid 47418156)
2. Bauml MA and Underwood DA. Left ventricular hypertrophy: an overlooked cardiovascular risk factor. Cleve Clin J Med 77: 381-387, 2010.
3. Beznak M. Hemodynamics during the acute phase of myocardial damage caused by isoproterenol. Can J Biochem Physiol 40: 25-30, 1962.
4. Beznak M and Hacker P. Hemodynamics during the Chronic Stage of Myocardial Damage Caused by Isoproterenol. Can J Physiol Pharmacol 42: 269-274, 1964.
5. Blaufarb IS and Sonnenblick EH. The renin-angiotensin system in left ventricular remodeling. Am J Cardiol 77: 8C-16C, 1996.
6. Collington SJ, Williams TJ, and Weller CL. Mechanisms underlying the localisation of mast cells in tissues. Trends Immunol 32: 478-485, 2011.
7. De Mello WC and Frohlich ED. On the local cardiac renin angiotensin system. Basic and clinical implications. Peptides 32: 1774-1779, 2011.
8. Doggrell SA and Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 39: 89-105, 1998. (Pubitemid 28322382)
9. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 153: 937-942, 1993. (Pubitemid 23124734)
10. Engels W, Reiters PH, Daemen MJ, Smits JF, and van der Vusse GJ. Transmural changes in mast cell density in rat heart after infarct induction in vivo. J Pathol 177: 423-429, 1995.
11. Facoetti A, Fallarini S, Miserere S, Bertolotti A, Ferrero I, Tozzi R, Gatti C, Palladini G, Perlini S, and Nano R. Histochemical study of cardiac mast cells degranulation and collagen deposition: interaction with the cathecolaminergic system in the rat. Eur J Histochem 50: 133-140, 2006. (Pubitemid 351467995)
12. Gradman AH and Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48: 326-341, 2006.
13. Grimm D, Elsner D, Schunkert H, Pfeifer M, Griese D, Bruckschlegel G, Muders F, Riegger GA, and Kromer EP. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37: 91-100, 1998. (Pubitemid 28122620)
14. Halova I, Draberova L, and Draber P. Mast cell chemotaxis- chemoattractants and signaling pathways. Front Immunol 3: 119, 2012.
15. Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, and Bian JS. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 9: 135-146, 2010.
16. Iwai N, Shimoike H, and Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 92: 2690-2696, 1995.
17. Junqueira LC, Bignolas G, and Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447-455, 1979. (Pubitemid 9238595)
18. Kabil O and Banerjee R. Redox biochemistry of hydrogen sulfide. J Biol Chem 285: 21903-21907, 2010.
19. Koda K, Salazar-Rodriguez M, Corti F, Chan NY, Estephan R, Silver RB, Mochly-Rosen D, and Levi R. Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation 122: 771-781, 2010.
20. Krop M, van Veghel R, Garrelds IM, de Bruin RJ, van Gool JM, van den Meiracker AH, Thio M, van Daele PL, and Danser AH. Cardiac Renin levels are not influenced by the amount of resident mast cells. Hypertension 54: 315-321, 2009.
21. Krum H. Role of renin in heart failure and therapeutic potential of direct renin inhibition. J Renin Angiotensin Aldosterone Syst 9: 177-180, 2008.
22. Kwon JS, Kim YS, Cho AS, Cho HH, Kim JS, Hong MH, Jeong SY, Jeong MH, Cho JG, Park JC, Kang JC, and Ahn Y. The novel role of mast cells in the microenvironment of acute myocardial infarction. J Mol Cell Cardiol 50: 814-825, 2011.
23. Levick SP, Melendez GC, Plante E, McLarty JL, Brower GL, and Janicki JS. Cardiac mast cells: the centrepiece in adverse myocardial remodelling. Cardiovasc Res 89: 12-19, 2011.
24. Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y, Yamamoto R, Ozasa Y, Fujimoto M, Wang P, Nakauchi H, Nakaya H, and Komuro I. Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 120: 242-253, 2010.
25. Liu YH, Lu M, Hu LF, Wong PT, Webb GD, and Bian JS. Hydrogen sulfide in the mammalian cardiovascular system. Antioxid Redox Signal 17: 141-185, 2012.
26. Lu M, Liu YH, Goh HS, Wang JJ, Yong QC, Wang R, and Bian JS. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 21: 993-1002, 2010.
27. Lu M, Liu YH, Ho CY, Tiong CX, and Bian JS. Hydrogen sulfide regulates cAMP homeostasis and renin degranulation in As4.1 and rat renin-rich kidney cells. Am J Physiol Cell Physiol 302: C59-C66, 2012.
28. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, and Levi R. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 116: 1063-1070, 2006.
29. Maeda Y, Inoguchi T, Takei R, Sawada F, Sasaki S, Fujii M, Kobayashi K, Urata H, Nishiyama A, and Takayanagi R. Inhibition of chymase protects against diabetes-induced oxidative stress and renal dysfunction in hamsters. Am J Physiol Renal Physiol 299: F1328-F1338, 2010.
30. Muders F and Elsner D. Animal models of chronic heart failure. Pharmacol Res 41: 605-612, 2000.
31. Panicker S, Swathy SS, John F, and M I. Impact of selenium on the leukotriene B4 synthesis pathway during isoproterenol-induced myocardial infarction in experimental rats. Inflammation 35: 74-80, 2012.
32. Paul M, Poyan Mehr A, and Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803, 2006. (Pubitemid 44033382)
33. Pearce RM. Experimental myocarditis; a study of the histological changes following intravenous injections of adrenalin. J Exp Med 8: 400-409, 1906.
34. Reid AC, Brazin JA, Morrey C, Silver RB, and Levi R. Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system. Curr Pharm Des 17: 3744-3752, 2011.
35. Reid AC, Silver RB, and Levi R. Renin: at the heart of the mast cell. Immunol Rev 217: 123-140, 2007. (Pubitemid 46718147)
36. Rona G, Chappel CI, Balazs T, and Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol 67: 443-455, 1959.
37. Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, and Levi R. Mast cells: a unique source of renin. Proc Natl Acad Sci USA 101: 13607-13612, 2004. (Pubitemid 39238450)
38. Teerlink JR, Pfeffer JM, and Pfeffer MA. Progressive ventricular remodeling in response to diffuse isoproterenolinduced myocardial necrosis in rats. Circ Res 75: 105-113, 1994.
39. Whiteman M, Le Trionnaire S, Chopra M, Fox B, and Whatmore J. Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools. Clin Sci (Lond) 121: 459-488, 2011.
40. Whittaker P, Kloner RA, Boughner DR, and Pickering JG. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 89: 397-410, 1994.
41. Zhang W, Chancey AL, Tzeng HP, Zhou Z, Lavine KJ, Gao F, Sivasubramanian N, Barger PM, and Mann DL. The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation 124: 2106-2116, 2011.